We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$547M
AUM Growth
-$9.74M
Cap. Flow
-$42M
Cap. Flow %
-7.68%
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$5.76M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$5.22M
3
COR icon
Cencora
COR
+$4.35M
4
NFLX icon
Netflix
NFLX
+$4.25M
5
SBUX icon
Starbucks
SBUX
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 29.46%
2 Technology 20.64%
3 Consumer Discretionary 10.94%
4 Financials 9.21%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFPT
76
DELISTED
Proofpoint, Inc.
PFPT
$2.55M 0.47%
40,090
-19,330
-33% -$1.14M
IFF icon
77
International Flavors & Fragrances
IFF
$20.6B
$2.45M 0.45%
22,430
+3,700
+20% +$427K
ESI icon
78
Element Solutions
ESI
$9.18B
$2.36M 0.43%
92,360
+57,290
+163% +$1.55M
MRK icon
79
Merck
MRK
$316B
$2.35M 0.43%
43,324
-7,714
-15% -$433K
UAA icon
80
Under Armour
UAA
$2.89B
$2.33M 0.43%
56,236
+50,193
+831% +$2.02M
ANET icon
81
Arista Networks
ANET
$233B
$2.18M 0.4%
+427,520
New +$1.91M
STDY
82
DELISTED
SteadyMed Ltd
STDY
$2.17M 0.4%
407,057
+344,668
+552% +$2.78M
EBS icon
83
Emergent Biosolutions
EBS
$382M
$2.15M 0.39%
65,220
-6,660
-9% -$206K
MIDD icon
84
Middleby
MIDD
$6.14B
$2.12M 0.39%
18,920
+17,880
+1,719% +$1.91M
INGN icon
85
Inogen
INGN
$182M
$2.12M 0.39%
47,540
+27,950
+143% +$1.07M
CNCE
86
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$2.09M 0.38%
140,620
-10,535
-7% -$160K
PZZA icon
87
Papa John's
PZZA
$1.02B
$2.09M 0.38%
27,670
+19,670
+246% +$1.31M
XPO icon
88
XPO
XPO
$23.1B
$2.05M 0.38%
131,240
+16,972
+15% +$275K
OZK icon
89
Bank OZK
OZK
$5.65B
$2.05M 0.38%
44,800
+5,532
+14% +$235K
AYI icon
90
Acuity Brands
AYI
$10B
$2.02M 0.37%
+11,230
New +$1.97M
SPSC icon
91
SPS Commerce
SPSC
$2.72B
$2.01M 0.37%
61,100
+31,720
+108% +$1.07M
PBH icon
92
Prestige Consumer Healthcare
PBH
$2.46B
$2M 0.37%
+43,340
New +$1.9M
CMG icon
93
Chipotle Mexican Grill
CMG
$47.4B
$1.94M 0.36%
160,500
-203,500
-56% -$2.57M
AMSG
94
DELISTED
Amsurg Corp
AMSG
$1.92M 0.35%
27,370
+27,330
+68,325% +$1.83M
CRDF icon
95
Cardiff Oncology
CRDF
$72.7M
$1.9M 0.35%
2,599
+982
+61% +$697K
AM
96
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
$1.89M 0.35%
+65,880
New +$1.77M
PGNX
97
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.89M 0.35%
252,785
-100,355
-28% -$607K
ARIA
98
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$1.86M 0.34%
225,090
+149,370
+197% +$1.32M
MLNX
99
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.85M 0.34%
+38,160
New +$1.85M
ATRC icon
100
AtriCure
ATRC
$1.97B
$1.85M 0.34%
75,000
-3,370
-4% -$75.3K

Similar funds

Turner Investments's Q2 2015 Portfolio in Review

As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.

  • Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
  • Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
  • Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
  • Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
  • Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
  • Turner Investments opened 78 new positions and closed 239 in Q2 2015.
  • Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.